European Journal of Ophthalmology最新文献

Non arteritic ischemic optic neuropathy in a patient taking semaglutide: Is there a relation? A case report and a review of the literature.

IF 1.4 4区医学

European Journal of Ophthalmology Pub Date : 2025-04-04 DOI: 10.1177/11206721251331655

Martina Maceroni, Paola Sasso, Matteo Giarletti, Valentina Bruno, Angelo Maria Minnella

{"title":"Non arteritic ischemic optic neuropathy in a patient taking semaglutide: Is there a relation? A case report and a review of the literature.","authors":"Martina Maceroni, Paola Sasso, Matteo Giarletti, Valentina Bruno, Angelo Maria Minnella","doi":"10.1177/11206721251331655","DOIUrl":"https://doi.org/10.1177/11206721251331655","url":null,"abstract":"IntroductionThe glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as Semaglutide, have revolutionized the treatment of type 2 diabetes mellitus and obesity.Case desciptionThe aim of the present study was to report a case of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) occurring in a diabetic patient taking Semaglutide and to review the literature in order to find a possible relation between the ophthalmological event and the drug intake.DiscussionAlthough the clinical trials of Semaglutide did not report any significant increase in the risk of NAION, a recent retrospective cohort study suggested a possible association between NAION and GLP-1 RAs. After this publication, the association between NAION and Semaglutide became an hot topic and several studies were published, presenting conflicting results.Conclusion and ImportanceAlbeit the association between the use of GLP-1 RAs and NAION, to date, remain controversial, clinicians and ophthalmologists should be aware of such possible association to analyze for each patient the risk-benefit ratio.","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"11206721251331655"},"PeriodicalIF":1.4,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143779313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Unexpected impact: Orbital fracture from pickleball trauma - a case report and literature review.

IF 1.4 4区医学

European Journal of Ophthalmology Pub Date : 2025-04-01 DOI: 10.1177/11206721251332977

Akshay Gopinathan Nair, Anika Narayanan

{"title":"Unexpected impact: Orbital fracture from pickleball trauma - a case report and literature review.","authors":"Akshay Gopinathan Nair, Anika Narayanan","doi":"10.1177/11206721251332977","DOIUrl":"https://doi.org/10.1177/11206721251332977","url":null,"abstract":"PurposeTo present a case of orbital fracture arising from a pickleball related injury.MethodsRetrospective case reportResultsPickleball is a fast-growing sport combining elements of tennis, badminton, and table tennis and injuries to the eye and adnexa from blunt trauma associated with pickleball are increasing. To date, no cases of orbital fractures arising from pickleball-associated trauma have been documented. We report the case of a 54-year-old male who sustained orbital trauma when his teammate's paddle struck his face. Examination revealed lid hematoma, a lower eyelid laceration, subconjunctival haemorrhage and periorbital edema. Imaging demonstrated a minimally displaced medial orbital wall fracture without muscle entrapment or bony impingement. The laceration was repaired, and the fracture was managed conservatively given the absence of diplopia or enophthalmos.Conclusions and importanceWhile on its own, an orbital fracture is a commonly encountered entity, the mode of injury and the nature of the trauma that led to the injury are extremely rare. This case highlights the potential for serious orbital injuries in pickleball, emphasizing the need for protective measures and increased awareness among players and healthcare providers. In this communication, we describe our case in detail and review the reported cases of pickleball related ophthalmic trauma.","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"11206721251332977"},"PeriodicalIF":1.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143763446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Brazilian case of extensive macular atrophy with pseudodrusen and non-exudative quiescent macular neovascularization.

IF 1.4 4区医学

European Journal of Ophthalmology Pub Date : 2025-04-01 DOI: 10.1177/11206721251333274

Dotnara de Faria Corrêa Roncato, Beatrice Tombolini, Luize de Faria Corrêa Roncato, Ricardo Japiassú, Nolvar Spessato, Riccardo Sacconi, Giuseppe Querques, Francesco Bandello

{"title":"A Brazilian case of extensive macular atrophy with pseudodrusen and non-exudative quiescent macular neovascularization.","authors":"Dotnara de Faria Corrêa Roncato, Beatrice Tombolini, Luize de Faria Corrêa Roncato, Ricardo Japiassú, Nolvar Spessato, Riccardo Sacconi, Giuseppe Querques, Francesco Bandello","doi":"10.1177/11206721251333274","DOIUrl":"https://doi.org/10.1177/11206721251333274","url":null,"abstract":"PurposeTo report a case of extensive macular atrophy with pseudodrusen (EMAP) complicated by a non-exudative quiescent type 1 macular neovascularization (MNV).Case descriptionA 65-years-old male patient complained of bilateral progressive visual loss and nyctalopia over the last ten years. Fundus examination showed in both eyes central foveal sparing geographic atrophy partially extending outside vascular arcades, reticular pseudodrusen (RPD), and mid-periphery pavingstone degenerations. On optical coherence tomography (OCT), RPD, basal laminar deposits, retinal pigmented epithelium and outer retinal atrophy were detected bilaterally. In left eye (LE), a perifoveal mid-reflective pigment epithelium detachment (PED) with no neovascular activity signs (e.g., macular hemorrhage, intraretinal/subretinal fluid, subretinal hyperreflective material) was found. Fluorescein angiography revealed in LE a hyperfluorescence coincident with PED without leakage on late phase. OCT-angiography displayed a pathological neovascular network consistent with a non-exudative type 1 neovascularization. No treatment was performed and the patient was closely followed. On last consultation six months later, MNV was stable with no identifiable activation signs. Based on these findings, a diagnosis of EMAP complicated by non-exudative quiescent type 1 neovascularization was hypothesized.DiscussionSimilarly to age-related macular degeneration, EMAP could be associated to non-exudative neovascularization. Choriocapillaris loss could be the trigger for the development of vascular sprouts, representing the precursor of non-exudative type 1 MNV.ConclusionThis case-report supported the importance of at least six-months follow-up for NE-MNV in EMAP. Further studies are needed to confirm our result and to consolidate therapeutic management of MNV in this rare macular disorder.","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"11206721251333274"},"PeriodicalIF":1.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143763438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Endocrine mucin-producing sweat gland carcinoma: Case report and literature review.

IF 1.4 4区医学

European Journal of Ophthalmology Pub Date : 2025-03-29 DOI: 10.1177/11206721251327644

Nan Guo, Zhenlin Fan, Yitong Chen, Qian Li, Limin Guo

{"title":"Endocrine mucin-producing sweat gland carcinoma: Case report and literature review.","authors":"Nan Guo, Zhenlin Fan, Yitong Chen, Qian Li, Limin Guo","doi":"10.1177/11206721251327644","DOIUrl":"https://doi.org/10.1177/11206721251327644","url":null,"abstract":"PurposeTo provide more basis for further diagnosis and differentiation for Endocrine Mucin-Producing Sweat Gland Carcinoma (EMPSGC), we offer a case report and a comprehensive review of the epidemiology, immunohistochemical findings, and molecular mechanisms underlying EMPSGC.Case descriptionWe herein present a case of a 70-year-old Chinese male patient who presented with a painless, progressively enlarging skin mass at his right lateral canthus. Histopathological examination revealed solid papillary growth patterns with intracellular mucin, and immunohistochemical staining was positive for Ki-67, P53, EMA, CK7, GATA3, CgA, Syn, INSM1, and AR, confirming the diagnosis of EMPSGC. Literature revealed that EMPSGC is a rare, low-grade malignant tumor with neuroendocrine differentiation. Key immunohistochemical markers include CK7, GATA-3, and INSM1, which aid in diagnosis. Hormone receptors such as ER, PgR, and AR are frequently expressed. The recurrence risk ranges from 7.11% to 14.3%, with rare cases of metastasis to the parotid gland, lungs, and skeletal system. Following surgical resection and subsequent pathological examination, the lesion was diagnosed as EMPSGC. In this report, we delineate the clinical presentation, Hematoxylin and eosin (H&E) staining features, and immunohistochemical characteristics of this case. We also conduct a literature review to enhance the understanding of EMPSGC.ConclusionEMPSGC is a relatively rare type of eyelid tumor in ophthalmic diagnosis and treatment. However, it poses a significant risk of misdiagnosis with other ocular tumors. Any eyelid mass demands attention, and necessitates prompt resection followed by intraoperative and/or postoperative pathological examination to avoid misdiagnose and poor prognosis.","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"11206721251327644"},"PeriodicalIF":1.4,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143742692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Efficacy of treatment with faricimab for patients with refractory nAMD.

IF 1.4 4区医学

European Journal of Ophthalmology Pub Date : 2025-03-26 DOI: 10.1177/11206721251328097

Nabila Jones, Christa Gore, Habiba Saedon, Clare O'Donnell, Sajjad Mahmood

{"title":"Efficacy of treatment with faricimab for patients with refractory nAMD.","authors":"Nabila Jones, Christa Gore, Habiba Saedon, Clare O'Donnell, Sajjad Mahmood","doi":"10.1177/11206721251328097","DOIUrl":"https://doi.org/10.1177/11206721251328097","url":null,"abstract":"ObjectiveTo investigate the efficacy of treatment with faricimab in patients with refractory neovascular age-related macular degeneration (nAMD).MethodsA Single-centre, retrospective cohort study was conducted on patients treated with faricimab for refractory nAMD. Outcome measures comprised best measured visual acuity (BMVA), central foveal thickness (CFT) on optical coherence tomography (OCT) and mean treatment interval for patients receiving six or more faricimab injections.ResultsCFT was shown to significantly decrease for all eyes (N = 52) treated with six faricimab injections (χ 52.88 df 5 p < 0.001) from baseline (274 ± 73 µm) and subsequent injections (244 ± 59 µm). BMVA remained stable (χ 6.45 df 5 p = 0.26) from baseline treatment (baseline, 67 letters ± 13) and subsequent injections with faricimab (67 letters ± 14, injection 6). Mean treatment interval with faricimab increased from 4.2 weeks to 5.8 weeks indicating sustained results. Zero cases of post-operative complications were reported.ConclusionThis study adds to the growing body of real-world evidence supporting the efficacy of faricimab in treating refractory nAMD. With improvements in anatomical outcomes and an extended treatment interval, whilst maintaining stable vision, faricimab emerges as a promising therapeutic option for patients with refractory nAMD.","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"11206721251328097"},"PeriodicalIF":1.4,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143709240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Evaluating semi-automated kinetic perimetry in persons with idiopathic intracranial hypertension.

IF 1.4 4区医学

European Journal of Ophthalmology Pub Date : 2025-03-25 DOI: 10.1177/11206721251329982

Simon J Hickman, Lucy Givens, Joanna M Jefferis, Irene M Pepper, Martin J Rhodes

{"title":"Evaluating semi-automated kinetic perimetry in persons with idiopathic intracranial hypertension.","authors":"Simon J Hickman, Lucy Givens, Joanna M Jefferis, Irene M Pepper, Martin J Rhodes","doi":"10.1177/11206721251329982","DOIUrl":"https://doi.org/10.1177/11206721251329982","url":null,"abstract":"BackgroundThis study aimed to assess whether semi-automated kinetic perimetry (SKP) enables the quantitation and monitoring of visual field loss in persons with idiopathic intracranial hypertension (PWIIH).MethodsWe conducted a retrospective review of newly diagnosed PWIIH. We recorded baseline clinical data and optic disc modified Frisén grade from fundal photographs. The SKP software calculated the I4e and I2e isopter areas and the I4e target plotted blind spot areas. This was recorded for each eye at baseline and for each study visit for up to 1 year.ResultsBoth the baseline I4e isopter (F = 44.1, p < 0.001) and I2e isopter areas (F = 37.1, p < 0.001) were significantly related to baseline visual acuity. The baseline blind spot area was significantly related to modified Frisén grade (F = 22.0, p < 0.001). There was no significant linear relationship between either the I4e isopter (F = 0.06; p = 0.939) or I2e isopter areas (F = 0.06, p = 0.807) and the time since diagnosis. There was, however a significant linear decrease in mean blind spot area over time (F = 46.6, p < 0.001).ConclusionsThe relationships at baseline between I4e and I2e isopter areas and visual acuity show that SKP provides clinically meaningful results at presentation in PWIIH. Our results suggest that it is less useful for monitoring recovery.","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"11206721251329982"},"PeriodicalIF":1.4,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143699955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Meibomian gland atrophy in Keratoconus: A case-control study.

IF 1.4 4区医学

European Journal of Ophthalmology Pub Date : 2025-03-23 DOI: 10.1177/11206721251327651

Camille Morice, Valentine Saunier, Maeva Kyheng, Pierre Fournie, David Touboul

{"title":"Meibomian gland atrophy in Keratoconus: A case-control study.","authors":"Camille Morice, Valentine Saunier, Maeva Kyheng, Pierre Fournie, David Touboul","doi":"10.1177/11206721251327651","DOIUrl":"https://doi.org/10.1177/11206721251327651","url":null,"abstract":"PurposeTo assess the Meibomian Gland Atrophy (MGA) in keratoconus patients by comparison to healthy controls.SettingFrench Keratoconus national reference center, Bordeaux, France.DesignObservational, monocentric, comparative case control study.MethodsEighty-eight keratoconic eyes free of any surgical treatment (KC group) and 88 healthy eyes (NKC group) matched for age and gender, included from December 2018 to May 2019, underwent infrared meibography providing a meiboscore of MGA (primary outcome measure), scaled from 0 to 6. Secondary outcomes including Lipid Layer Thickness (LLT) assessment using interferometry, Tear Break-Up Time (T-BUT) evaluated by a slit lamp examination, corneal OCT-based topography, and two dry eye questionnaires (OSDI and SPEED) filled by the patients during the consultation.ResultsA significant difference in distribution of meiboscore scores between groups (p < 0.0001 for total, superior and inferior meiboscore) was found, with lower scores in controls compared to eyes with keratoconus. Using a cut-off value of ≥2 as abnormal meiboscore, 64.8% of eyes of cases had abnormal meiboscore by comparison to only 27.3% of controls (OR, 4.91; 95%CI, 2.56 to 9.38). Patients with keratoconus had higher OSDI (mean difference 15.3, 95%CI 1.8 to 1.7) and SPEED (mean difference 2.5, 95%CI 2.5 to 4.5) results. No significant difference was found in T-BUT whereas keratitis was more common in cases.ConclusionKeratoconus was associated with higher meibomian gland atrophy in this study.","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"11206721251327651"},"PeriodicalIF":1.4,"publicationDate":"2025-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143691231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Unravelling advanced glycation end products as emerging therapeutic targets in diabetic retinopathy management.

IF 1.4 4区医学

European Journal of Ophthalmology Pub Date : 2025-03-23 DOI: 10.1177/11206721251328562

Sandeep Saxena, Nibha Mishra, Gemmy Cheung, Srinivas R Sadda

{"title":"Unravelling advanced glycation end products as emerging therapeutic targets in diabetic retinopathy management.","authors":"Sandeep Saxena, Nibha Mishra, Gemmy Cheung, Srinivas R Sadda","doi":"10.1177/11206721251328562","DOIUrl":"https://doi.org/10.1177/11206721251328562","url":null,"abstract":"Diabetes mellitus, characterized by chronic hyperglycemia, is a rapidly growing global health concern with an anticipated prevalence of 700 million by 2045. Diabetic retinopathy (DR), a major complication, is the leading cause of vision loss in working-age adults worldwide. Neurovascular units (NVUs), comprising neurons, glial cells, and vessels, maintain retinal homeostasis, and their impairment is considered a primary pathological change in early DR. While glycemic control is conventionally assessed by hemoglobin A1c (HbA1c), studies suggest additional factors influencing DR risk beyond equivalent HbA1c levels. Chronic hyperglycemia triggers neurovascular impairment through advanced glycation end-products (AGEs), inflammation, and oxidative stress. AGEs, accumulating irreversibly, play a crucial role in DR and other diabetic complications. Therapeutic interventions targeting AGEs, both endogenous and exogenous, are gaining traction, offering potential avenues to preserve NVU function. Existing drugs such as pioglitazone, angiotensin II receptor blockers, ACE inhibitors, calcium channel blockers, and statins, along with natural compounds like benfotiamine and cinnamon bark extract, show promise as anti-AGE strategies. This multifaceted approach presents a paradigm shift in early diabetic retinopathy treatment, with ongoing research focusing on refining these strategies for improved management.","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"11206721251328562"},"PeriodicalIF":1.4,"publicationDate":"2025-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143691147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comparing the outcome of delayed postoperative versus intraoperative mitomycin C use in trabeculectomy: A randomized control trial.

IF 1.4 4区医学

European Journal of Ophthalmology Pub Date : 2025-03-23 DOI: 10.1177/11206721251327650

Ashok Kumar Singh, Natasha Gautam, Faisal Thattaruthody, Madhuri Akella, Srishti Raj, Sushmita Kaushik, Surinder Singh Pandav

{"title":"Comparing the outcome of delayed postoperative versus intraoperative mitomycin C use in trabeculectomy: A randomized control trial.","authors":"Ashok Kumar Singh, Natasha Gautam, Faisal Thattaruthody, Madhuri Akella, Srishti Raj, Sushmita Kaushik, Surinder Singh Pandav","doi":"10.1177/11206721251327650","DOIUrl":"https://doi.org/10.1177/11206721251327650","url":null,"abstract":"PurposeTo compare the effect of delayed postoperative mitomycin C (MMC) application on surgical outcome and bleb morphology with intra-operative application in trabeculectomy.MethodThis monocentric, unmasked randomized control trial recruited primary glaucoma patients between 18-70 years of age. They were randomized into Group I (intraoperative MMC group) and Group II (postoperative MMC group). All patients underwent standard fornix-based trabeculectomy with differences only in the MMC application step. In Group I, 0.2 mg/ml MMC was applied intraoperatively for two minutes, while in Group II, 0.01 mg (0.25 ml of 0.04 mg/ml) of MMC was injected 7-14 days postoperatively above the bleb. The primary outcome was surgical success, whereas the secondary outcome measures were rate of complications and bleb morphology. Complete and qualified success was defined as intraocular pressure (IOP) between 6-21 mm Hg without and with ≤2 anti-glaucoma medications (AGMs).ResultsFifty-six eyes (31 in Group I and 25 in Group II) were analyzed for the outcome at 18 months follow-up. Surgical success was comparable (70.9% vs 68%) (p = 0.811) between the groups. There were higher incidences of hypotony (41.9% vs 36%) in Group I. Incidences of persistent-hypotony (p = 0.032) and late-hypotony (p = 0.127) were higher in Group I. Two eyes developed hypotony maculopathy in Group I, while none in Group II. The blebs in Group I were more avascular, cystic and developed thinning, while those in Group II were diffuse and shallow.ConclusionsDelayed postoperative MMC application may be as effective as standard trabeculectomy with MMC in lowering IOP with a lower rate of complications.","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"11206721251327650"},"PeriodicalIF":1.4,"publicationDate":"2025-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143691221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Enhancing safety of transscleral diode cyclophotocoagulation: Check the tip before use.

IF 1.4 4区医学

European Journal of Ophthalmology Pub Date : 2025-03-23 DOI: 10.1177/11206721251327643

Francesco Matarazzo, Soledad Aguilar-Munoa, Eleni Nikita

引用次数: 0